Claims
One word, two bottles: nerve against neuropathy
One word separates a claim a supplement may make from one only a drug may make. On this product that word appears on the marketing bottle and not on the real one. It is the cleanest illustration of a regulatory line this desk has had, and it is worth being precise about what it does and does not show.
The label reads NERVE SUPPORT FORMULA. The marketing graphic reads NEUROPATHY SUPPORT FORMULA. Same bottle, two renderings, one word apart. Nerve support is a structure/function claim: it describes a normal body system, it is lawful, and it carries the FDA disclaimer printed in full on the same label. Neuropathy is a named medical condition, and the FDA’s own page on structure/function claims explains that the mandatory disclaimer exists precisely because a supplement is not intended to diagnose, treat, cure or prevent a disease — “because only a drug can legally make such a claim”. Where the two documents disagree, the label is the product. And one limit matters as much as the finding: this is an observation about artwork, not about contents.
- On the label
- NERVE SUPPORT FORMULA*
- On the marketing graphic
- NEUROPATHY SUPPORT FORMULA
- Times it appears there
- Twice
- Claim type on the bottle
- Structure/function
- Claim type in the graphic
- Names a disease
- FDA disclaimer on the label
- Printed in full
- Which document is the product
- The label
- What this says about contents
- Nothing
One bottle, two renderings
Begin with the transcription, because everything else is downstream of it. The flat label artwork supplied with this product carries five lines on its front panel, and they are reproduced here exactly as printed:
- Neuralisse
- NERVE SUPPORT FORMULA*
- DIETARY SUPPLEMENT
- 30 CAPSULES
- ONCE DAILY
Three asterisked icons sit alongside them: NERVE HEALTH* · COMFORT SUPPORT* · NUTRITIONAL SUPPORT. The asterisks point at the FDA disclaimer, which is printed in full elsewhere on the same label. There is no disease word anywhere on the bottle.
The Inside Neuralisse marketing graphic then renders the same bottle with the words NEUROPATHY SUPPORT FORMULA in the same position, twice within the one image. That is the whole of the finding: one word, in one place, on a document that is not the bottle.
| Claim | Where it appears |
|---|---|
| Nerve Support Formula | Printed on the label, front panel |
| Nerve Health* | Printed on the label, front panel icon |
| Comfort Support* | Printed on the label, front panel icon |
| Nutritional Support | Printed on the label, front panel icon |
| Neuropathy Support Formula | Marketing graphic only — not on the label |
| Nerve-comfort positioning by name. Not a drug. | Seller pack, in its own words |
Read the fifth row against the first. The label’s own front panel says nerve support formula; the graphic used to sell it says neuropathy support formula; and the seller’s own internal pack, in its own words, describes the product as nerve-comfort positioning by name — not a drug. Somebody understood the distinction. The artwork does not reflect it.
The graphic itself
Nothing has been altered, cropped to mislead or annotated. The image is reproduced because a reader is entitled to see the document a finding rests on, and because a transcription of a graphic is weaker evidence than the graphic.
Two things this desk does not claim about it, stated so that nobody has to wonder. It does not claim to know how the image was produced, who drew it or in what sequence. And it does not claim to know why the word differs from the label — nothing supplied explains the difference, and no explanation appears in any document received. The gap is recorded as a gap.
What a structure/function claim is
Here is the sentence the whole distinction comes from, in the FDA’s own words rather than paraphrased:
“Structure/function claims may describe the role of a nutrient or dietary ingredient intended to affect the normal structure or function of the human body … the disclaimer must state that the product is not intended to “diagnose, treat, cure or prevent any disease,” because only a drug can legally make such a claim.”
U.S. Food and Drug Administration — Structure/Function Claims
The first half is permission. A supplement may describe the role of a nutrient or dietary ingredient in affecting the normal structure or function of the human body. Supports nerve health. Supports comfort. Nutritional support. Those are the three asterisked icons on this bottle, and all three are lawful claims.
Three features make a claim of that kind what it is. It describes a normal function rather than a disordered one. It names no condition. And it arrives with a disclaimer, which is the price of making it — not an apology attached to a medical claim, but the condition on which a non-medical one may be printed.
It is worth noticing how undemanding that is as a standard. A structure/function claim does not require clinical evidence of effect in the product, does not require a particular amount of an ingredient, and does not require any route of action to be stated. None is stated in any document supplied for this product. A reader who treats supports nerve health as a finding about the capsule has read a great deal more into it than the phrase carries.
What a disease claim is
A disease claim says that a product diagnoses, treats, cures, mitigates or prevents a named condition. It is not a stronger version of the claim above; it is a different kind of statement, available to a different kind of product.
The FDA’s sentence gives the reason in nine words: “because only a drug can legally make such a claim”. Making it lawfully means being a drug — which means clinical evidence, a review before marketing, and an approved use. That route exists. It is simply not the route a dietary supplement has taken.
Neuropathy is a named medical condition. It is diagnosed, it has causes that are investigated, and it is managed by clinicians. Printing the word on a bottle of capsules places that bottle, rhetorically, in the category of things that address it — a category the product has not entered and does not claim on its own label to have entered.
What that means for somebody reading the graphic
If the word neuropathy is the reason this product looked relevant, the honest position is this: nothing about this bottle has been assessed by anybody as a treatment for neuropathy, and the bottle itself does not say it has. Nerve symptoms that have not been explained by a clinician are a reason to see one. A graphic is not a second opinion.
Why the line exists at all
The distinction can look like paperwork until you see what sits behind it, which is the fact that nobody checked this product before it went on sale.
“Under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed.”
U.S. Food and Drug Administration — Questions and Answers on Dietary Supplements
That is the whole foundation. Dietary supplements are not approved before marketing. Nobody vetted the words on the front of this bottle, nobody assessed the formula, and responsibility for both sits with the company that makes and markets it. The disclaimer on the label is the public notice of that arrangement.
Now the line makes sense as a consumer protection rather than as a formality. If a product has not been reviewed, the one thing a rule can do is stop it claiming to treat conditions — because a claim to treat a condition is exactly the claim a person with that condition will act on, and acting on it means not doing something else. The line is drawn where the harm is: between describing a body system and promising to fix a diagnosis.
It also explains why a disclaimer printed in full is a credit rather than a confession. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. That sentence appears on this label, and a label without it beside a structure/function claim would be the thing worth noticing.
The label is careful, and gets credit for it
It would be easy to read this piece as a verdict on the whole product. It is not. On this specific question the label is careful, and the care is worth itemising because several labels in this series are not.
What the label gets right on claims
- No disease word anywhere on the bottle. The front panel says nerve support formula and stops.
- Three asterisked icons. Nerve health, comfort support and nutritional support — all three marked, all three tied to the disclaimer.
- The FDA disclaimer printed in full, both sentences, not abbreviated and not buried.
- A complete caution block, including a direction to consult a physician if you take a medication or have a medical condition — which is the sentence that matters to a reader with a real symptom.
- The seller’s own internal pack describes the product as “not a drug.” Somebody wrote the distinction down before any of this was drawn.
What the artwork gives back
- NEUROPATHY SUPPORT FORMULA on the same bottle in the Inside graphic, twice in one image.
- No explanation anywhere. Nothing supplied to this desk accounts for the difference between the two renderings.
- No disclaimer visible beside the stronger word in the graphic that carries it.
- Three supplied seals — a GMP mark, a non-GMO mark and a money-back mark — none of which appears on the label either.
That is why the editorial score on this site gives claim accuracy two out of five rather than one or four. The label earns marks; the artwork gives them back. Both halves are published and neither cancels the other out.
What a reader should do when the two disagree
This situation is commoner than one word on one bottle, so the response is worth writing as a procedure rather than as advice about this product.
- 01Write both down, word for word, before you decide anythingNERVE SUPPORT FORMULA from the label. NEUROPATHY SUPPORT FORMULA from the Inside Neuralisse graphic. Transcribe them rather than paraphrasing them, because the finding is a single word and a paraphrase destroys it.
- 02Work out which document is the productThe label is printed on the bottle that arrives at your door. A marketing graphic is a file that can be redrawn tonight without telling anybody and without recalling a single bottle. The label is the product. That is not a preference; it is the difference between a document with rules attached and a picture.
- 03Check which side of the regulatory line each one sits onNerve support describes a body system: a structure/function claim, lawful with the disclaimer attached. Neuropathy names a medical condition. The FDA’s own page is explicit that a supplement is not intended to diagnose, treat, cure or prevent a disease, because only a drug can legally make such a claim.
- 04Ask what you were actually being soldIf the disease word is the reason you are interested, that word did not come from the product. Nothing about this bottle has been assessed, by anybody, as a treatment for a named condition — and the bottle itself does not say it has. The gap is between you and the artwork, not between you and the label.
- 05Take the panel to the appointment, not the advertisementA clinician can read a Supplement Facts panel. A clinician cannot do anything with a marketing graphic. If you want a view on whether this is worth taking alongside whatever else you take, the ruled box is the document to show.
- 06Keep the artworkScreenshot it with the date visible. Artwork changes; a screenshot does not. If you ever need to describe to anybody what you were shown before you bought something, that file is the only record you will have, because the seller’s version can be replaced at any time.
Step two is the whole of it and it is worth repeating in isolation. The label is the product. The bottle that arrives carries the label; the label is the document with rules attached to it; the graphic is a file. Where they differ, print both and believe the bottle.
The limits of this inference
A good finding is lost by overstating it, and this one is easy to overstate. So here is precisely what it supports and precisely what it does not.
| Claim | Supported? | Why |
|---|---|---|
| The two documents carry different words on the same bottle | Yes | Both were transcribed from the material supplied and both are reproduced on this site. |
| Neuropathy names a medical condition and nerve support does not | Yes | One names a diagnosis; the other names a body system. The FDA’s own page draws the distinction. |
| A supplement may not claim to treat a named disease | Yes | Quoted directly: only a drug can legally make such a claim. |
| The label stays inside structure/function language | Yes | No disease word appears anywhere on the bottle, and the disclaimer is printed in full. |
| Something is wrong with what is in the capsule | No | This finding is about words on artwork. It says nothing whatever about contents. The contents question is answered by the panel and by arithmetic, separately. |
| The product is unsafe | No | Nothing here speaks to safety. At 80 mg of magnesium the capsule sits at about 23% of the published upper limit for supplemental magnesium, which is a point in its favour. |
| The manufacturer intended to mislead | No | Nothing supplied establishes intent, and this desk does not infer it. The seller’s own pack wrote down that the product is not a drug, which cuts against the inference rather than for it. |
| A regulator has taken any view of this product | No | None of the nine sources cited on this site mentions this product. Not one was written about it. |
Keep the two questions apart and both get answered properly. What is in the capsule? is settled by the panel, and on this label it is settled unusually well: about 567.5 mg of magnesium glycinate and roughly 7.5 mg for the other five together. That derivation is published step by step. What is this being sold as? is the question in this piece, and the answer is that it is being sold with one more word than it is printed with.
Running the same check on any product
The check takes a few minutes on any supplement and it is one of the highest-yield things a reader can do, because it needs no chemistry and no arithmetic at all.
- 01Collect every rendering of the product you can findThe flat label artwork, the bottle photographs, the listing graphics, the advertisement, the packaging shots. Each one is a separate document and each one may carry different words on the same bottle.
- 02Transcribe the front panel from each, exactlyLine by line, including asterisks and capitalisation. Asterisks matter: they are the device that ties a structure/function claim to the mandatory disclaimer, and a graphic that drops them has dropped the link.
- 03Underline every noun that names a conditionNot a symptom, not a body part, not a system — a condition. Nerve, comfort and support are not conditions. Neuropathy is. This is the whole of the test and it takes a minute.
- 04Check whether the disclaimer travels with the claimOn this product the label prints the FDA statement in full. Ask whether the graphic carrying the stronger word carries the disclaimer too, because a claim and its disclaimer are supposed to arrive together.
- 05Publish both and name which is the productDo not resolve the disagreement by choosing the version you prefer or the one that reads better. Print both, say the label is the product, and leave the gap visible. The gap is the finding.
- 06Stop at the artwork, and say soA disease word on a graphic is evidence about how a product is being sold. It is not evidence about what is in a capsule, about safety, or about whether the manufacturer did anything else wrong. Overstating it is the fastest way to lose a good finding.
Run on this product, that sequence turns up one word, in one place, twice. Run on others in this series it has turned up different things. What makes it worth doing every time is step three: the test is a single question — does this wording name a condition? — and almost nobody asks it, which is precisely why the stronger word tends to live on the document nobody reads carefully.
References
Two sources carry this piece, both opened and read: the FDA’s page on structure/function claims, which draws the line, and its questions-and-answers page on dietary supplements, which explains why the line exists.
- U.S. Food and Drug Administration (2026). Structure/Function Claims.
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements.
Every quotation above is copied from the page linked here. Neither document mentions Neuralisse, and neither was written about it; they are quoted for the distinction they draw, not for any view of this product.
Read the blend row before you decide
Thirty capsules, one a day. The panel declares 80 mg of magnesium at 19% of the Daily Value, and a 575 mg blend of six ingredients. The magnesium declaration fixes the weight of the first ingredient at about 567.5 mg, which leaves roughly 7.5 mg for the other five together. No price appears anywhere but the checkout.
- Guarantee as printed at checkout
- 80 mg magnesium, 19% of the Daily Value
- Returns to 4 Times Square, Floor 22, New York, NY 10036, USA
No price appears in any document supplied to this desk, as of October 11, 2026, so none is printed here. The checkout screen is the only place a price exists. Questions first? Every published contact route is here.
Keep reading
Authorship and review
Who wrote and checked this page
What this page was checked against
- The label artwork, read at 2× and transcribed character for character. Where the label and the marketing disagree, the label is printed.
- The seller pack, quoted rather than paraphrased, and identified as marketing wherever it is used.
- The published sources listed in the references on this page. Every one was opened and read; none is cited from memory.
- The arithmetic, shown in full. Every per-ingredient figure other than the magnesium is a ceiling derived from one printed number, never a measured amount.
- Nothing else. Any fact that was not supplied is recorded as not published rather than filled in.
Last updated October 11, 2026. A highlighted slot is a value no human has supplied yet. Who reviews these pages?